These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8539716)

  • 1. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-Scl-70 antibodies in systemic scleroderma].
    Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
    Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort.
    Foeldvari I; Nihtyanova SI; Wierk A; Denton CP
    J Rheumatol; 2010 Nov; 37(11):2422-6. PubMed ID: 20843905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
    Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
    Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification criteria of scleroderma].
    Cabane J;
    Presse Med; 2006 Dec; 35(12 Pt 2):1916-22. PubMed ID: 17159717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma overlap syndromes.
    Bennett RM
    Rheum Dis Clin North Am; 1990 Feb; 16(1):185-98. PubMed ID: 2406807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.
    Akesson A; Wollheim FA
    Br J Rheumatol; 1989 Aug; 28(4):281-6. PubMed ID: 2787182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
    Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
    Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scleroderma].
    Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
    Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease.
    Norman DA; Fleischmann RM
    Arthritis Rheum; 1978; 21(7):811-9. PubMed ID: 308806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.
    Pagalavan L; Ong SG
    Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unusual manifestation of scleroderma of the trunk].
    Hackel H; Zillikens D; Lechner W; Burg G
    Hautarzt; 1990 Feb; 41(2):91-3. PubMed ID: 2180858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.